Clinical Study in the Treatment of Patients With Moderate Course of COVID-19
Phase 2
- Conditions
- COVID-19
- Interventions
- Drug: COVID-globulinDrug: Placebo
- First Posted Date
- 2021-04-13
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- Microgen
- Target Recruit Count
- 376
- Registration Number
- NCT04842435
- Locations
- ๐ท๐บ
2. State Budgetary Institution of Healthcare of the Moscow Region "Zhukovskiy City Clinical Hospital", Zhukovskiy, Russian Federation
๐ท๐บ15. Municipal Autonomous Institution "Central City Clinical Hospital No. 24", Ekaterinburg, Russian Federation
๐ท๐บ5. Saint Petersburg State Budgetary Healthcare Institution "City Hospital No. 40 of the Kurortny Region", Saint Petersburg, Russian Federation
ยฉ Copyright 2025. All Rights Reserved by MedPath